Apparatus and method of determining facial expression type
    13.
    发明授权
    Apparatus and method of determining facial expression type 有权
    确定面部表情类型的装置和方法

    公开(公告)号:US09355304B2

    公开(公告)日:2016-05-31

    申请号:US14553972

    申请日:2014-11-25

    CPC classification number: G06K9/00308

    Abstract: A method of determining a facial expression type may include extracting feature points representing facial characteristics from a facial image of a user; grouping the extracted feature points into a plurality of regions; and determining a facial expression type for each of a plurality of groups using feature points and a facial expression type function corresponding to each of the groups.

    Abstract translation: 确定面部表情类型的方法可以包括从用户的面部图像提取表示面部特征的特征点; 将所提取的特征点分组成多个区域; 以及使用特征点和对应于每个组的面部表情类型函数来确定多个组中的每个组的面部表情类型。

    SYSTEM FOR SCREENING THERAPEUTIC AGENTS FOR CORONAVIRUS INFECTION

    公开(公告)号:US20230242901A1

    公开(公告)日:2023-08-03

    申请号:US17778197

    申请日:2020-09-29

    CPC classification number: C12N15/1055

    Abstract: The present invention relates to a screening composition for a therapeutic agent for coronavirus infection, comprising a CoV RdRp expression vector and a bicistronic reporter vector, a screening kit for a therapeutic agent for coronavirus infection, comprising the composition, and a method for screening a therapeutic agent for coronavirus infection using the composition or kit. When the screening composition for a therapeutic agent for coronavirus infection, provided by the present invention, is used, candidate materials that can have direct influences on the activity of CoV RdRp can be screened more quickly and easily, and thus, the composition can be widely used in the development of therapeutic agents for coronavirus infection.

    COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING SLEEP DISORDERS COMPRISING MEDICINAL HERB EXTRACT AS EFFECTIVE INGREDIENT

    公开(公告)号:US20210145912A1

    公开(公告)日:2021-05-20

    申请号:US17058861

    申请日:2019-05-23

    Abstract: A method for treating a sleep disorder according to an embodiment of the present disclosure includes administering a composition comprising an extract of Hibiscus syriacus as an effective ingredient to a subject in need thereof. Because the Hibiscus syriacus extract of the present invention has an effect of improving sleep time deteriorated by stress, and an effect of reducing the content of corticosterone, which increases due to stress, and increasing the content of serotonin in blood. In addition, the composition has an effect of enhancing in a significant sense the expression of GABAR A α1 in cerebral cortex, which decreases due to stress, in a group administered with Hibiscus syriacus extract. As such, the composition comprising Hibiscus syriacus extract as an effective ingredient as an effective ingredient can be advantageously used as a functional health food composition or a pharmaceutical composition for preventing, ameliorating or treating sleeping disorders.

Patent Agency Ranking